Startups to Watch: SPR Therapeutics

January 17th, 2017 | News


SPR Therapeutics has developed a peripheral nerve stimulation therapy to address chronic pain syndromes in the back, limbs, and shoulder, as well as acute pain following joint replacement surgery. Delivered percutaneously for 30 days, the company’s FDA-cleared single-use disposable PNS platform has the potential to revolutionize pain management, offering a device-based alternative to highly addictive opioid drugs.

Continue reading here…

Comments are closed.